Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes

Models of pediatric acute megakaryoblastic leukemia lead to new potential therapies

Acute Lymphoblastic Leukemia (ALL)

The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target

Role of CD19 Chimeric Antigen Receptor T Cells in Second-Line Large B Cell Lymphoma: Lessons from Phase 3 Trials. An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

City of Hope presents pivotal clinical trial data at American Society of Hematology (ASH) conference on revumenib, a potential new targeted therapy for high-risk subtypes of acute leukemias

Acute lymphoblastic leukemia - Wikipedia

NPM1-mutated acute myeloid leukemia: from bench to bedside - ScienceDirect

Epigenetics and chemoresistance in childhood acute lymphoblastic leukemia

Acute Myeloid Leukemia - Ask Hematologist